Interaction of SCoV-2 NSP7 or NSP8 alone may cause constriction of the RNA entry channel in NSP12: Implications for novel RdRp inhibitor drug discovery
暂无分享,去创建一个
M. Kumar | M. Côté | M. Katika | K. K. Inampudi | Saroj Kumar | D. Sehgal | Tushar Kushwaha | M. B. Appaiahgari | Rajkumar Kulandaisamy | Kamal Baswal | Aparoy Polamarasetty | Vikas Kumar | Deepa Singh | Saras H Tiwari | Arkadyuti Ghorai | Suresh Gadde | Sarala R Kayampeta
[1] A. Kulbachinskiy,et al. Effects of natural RNA modifications on the activity of SARS‐CoV‐2 RNA‐dependent RNA polymerase , 2022, The FEBS journal.
[2] B. Hong,et al. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay , 2022, Frontiers in Immunology.
[3] Jimin Wang,et al. Insights into Binding of Single-Stranded Viral RNA Template to the Replication–Transcription Complex of SARS-CoV-2 for the Priming Reaction from Molecular Dynamics Simulations , 2022, Biochemistry.
[4] Wei Cheng,et al. Structural biology of SARS-CoV-2: open the door for novel therapies , 2022, Signal Transduction and Targeted Therapy.
[5] E. Campbell,et al. Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design , 2021, Nature reviews. Molecular cell biology.
[6] Tadeo E. Saldaño,et al. Analysis of changes of cavity volumes in predefined directions of protein motions and cavity flexibility , 2021, J. Comput. Chem..
[7] E. Koonin,et al. Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides , 2021, mBio.
[8] G. Blaha,et al. Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP , 2021, Nucleic acids research.
[9] P. Chaudhary,et al. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 , 2021, Cells.
[10] Hualiang Jiang,et al. Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin , 2021, Nature Structural & Molecular Biology.
[11] Liang-Tzung Lin,et al. Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects , 2021, Frontiers in Immunology.
[12] M. Zazzi,et al. SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19 , 2021, Expert opinion on therapeutic patents.
[13] Tieliu Shi,et al. Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics , 2021, Biochemical Pharmacology.
[14] D. Tegunov,et al. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir , 2021, Nature communications.
[15] Ji-min Cao,et al. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development , 2020, Frontiers in Cellular and Infection Microbiology.
[16] M. Munir,et al. Structural and functional insights into non-structural proteins of coronaviruses , 2020, Microbial Pathogenesis.
[17] V. Thiel,et al. Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.
[18] Zhènglì Shí,et al. Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.
[19] Md. Imtaiyaz Hassan,et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach , 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[20] G. Gao,et al. Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2 , 2020, Cell Reports.
[21] J. Mudgal,et al. COVID-19: Emergence, Spread, Possible Treatments, and Global Burden , 2020, Frontiers in Public Health.
[22] Rei-Lin Kuo,et al. COVID-19: The first documented coronavirus pandemic in history , 2020, Biomedical Journal.
[23] Dimitry Tegunov,et al. Structure of replicating SARS-CoV-2 polymerase , 2020, Nature.
[24] L. Guddat,et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus , 2020, Science.
[25] Yan Zhang,et al. Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir , 2020, bioRxiv.
[26] A. Ward,et al. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors , 2019, bioRxiv.
[27] E. Decroly,et al. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities , 2014, Proceedings of the National Academy of Sciences.
[28] Dmitri I. Svergun,et al. Nonstructural Proteins 7 and 8 of Feline Coronavirus Form a 2:1 Heterotrimer That Exhibits Primer-Independent RNA Polymerase Activity , 2012, Journal of Virology.
[29] Eric J. Snijder,et al. The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension , 2011, Nucleic acids research.
[30] J. Arnold,et al. The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent , 2009, Nucleic acids research.
[31] Torsten Schwede,et al. The SWISS-MODEL Repository and associated resources , 2008, Nucleic Acids Res..
[32] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[33] Jianping Ding,et al. Expression, purification, and characterization of SARS coronavirus RNA polymerase , 2005, Virology.
[34] Carla Schmidt,et al. Quantitative Cross-Linking of Proteins and Protein Complexes. , 2021, Methods in molecular biology.